FlashDx Inc

FlashDx is a company that specializes in near-patient molecular syndromic testing solutions. The company offers a range of products, including the sSPRT 4T/8T/12T Sample-to-Answer Molecular Test System, which is powered by its proprietary semi-Solid Phase Real-Time PCR (sSPRT) technology. This system provides highly multiplexed, true sample-to-answer solutions with a simple workflow, allowing for the detection of various diseases and sample types. FlashDx's product portfolio includes test cartridges for respiratory pathogens, arboviruses, SARS-CoV-2, and reproductive tract infections, among others. The company's goal is to provide fast, accurate, and affordable molecular testing solutions for use in point-of-care settings, with the aim of expanding its portfolio to include oncology and other disease areas.

Founded by US and European industry experts with Silicon Valley knowhow, FlashDx Inc offers a turn-key sample-to-answer Molecular test platform based on proprietary sSPRT™ (semi-Solid Phase Real-Time PCR) technologies. Product portfolio includes syndromic infectious test cartridges and scalable systems. The portfolio will expand to oncology and other disease areas.

Fast and accurate multiplexed molecular tests to anyone, anywhere. Multiplexed molecular point-of-care system, built on FlashDx's proprietary semi-Solid Phase Real Time PCR (sSPRT™) technology, delivers simple, fast and comprehensive results within one hour.

2018